Article,

Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and .
Liver Int, 43 (8): 1663-1676 (May 2023)
DOI: 10.1111/liv.15602

Meta data

Tags

Users

  • @pietschmann

Comments and Reviews